Drug-eluting beads loaded with irinotecan to treat synchronous liver-only metastases of colorectal cancer non-responsive to bevacizumab-based chemotherapy.

Pin-Ko ChenKai-Hsiang KoWei-Chou ChangTing-Fu HsuSung-Hua ChiuPing-Ying ChangHsuan-Hwai Lin

Published in: The British journal of radiology (2023)

DEBIRI can act as an acceptable locoregional management in CRC patients with liver metastases non-responsive to BBC, and the pre-DEBIRI CER is a potential indicator of locoregional control.

Keyphrases

liver metastases
cancer therapy
drug delivery
locally advanced
metastatic colorectal cancer
risk assessment
radiation therapy
wound healing
climate change
chemotherapy induced